CPT code 88166 covers cytopathology laboratory work in which a lab analyst manually analyzes a cervical or vaginal cytology slide and then rescreens the same slide using computer assistance under physician supervision, with results reported using the Bethesda System. This code matters nationally because cervical cancer screening and surveillance rely on accurate cytologic interpretation, and incorporation of computer-assisted rescreening is increasingly part of laboratory workflows and quality assurance practices.

Key payers in the scope of this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what 88166 represents clinically and operationally, payer coverage context, common billing considerations, and where this service typically occurs. The publication summarizes benchmarks and payment policy implications relevant to laboratories, pathology groups, and billing teams, and it highlights clinical context around cytology testing and the Bethesda reporting standard.

This report does not provide state-specific guidance. Data not available in the input is noted where applicable.